Receptos, Inc.
  • home
  • about
    • executive team
    • board of directors
    • scientific founders
    • scientific advisory board
    • clinical advisory board
    • investors
  • clinical
    pipeline
    • RPC1063
    • S1P1 additional indications
    • what is multiple
      sclerosis (MS)?
  • research &
    technology
    • information-driven drug design for G protein-coupled receptors (GPCRs)
    • untapped potential in the GPCR superfamily
    • small molecule GLP-1 agonist program for type 2 diabetes
  • corporate partnering
    • corporate fact sheet
  • news & publications
    • news
    • publications
  • contact
    • directions
    • careers
  • news
    • press releases
    • in the news
  • publications
    • S1P1
    • Structural Biology

news & publications

Press Releases

February 16, 2012 Receptos Scientists Publish Determination of a High Resolution
Sphingosine 1-Phosphate Receptor 1 Structure in Science
January 10, 2012 Receptos Achieves Milestone Under License of G-Protein Coupled
Receptor Crystal Structure Determination Technology
December 12, 2011 Receptos and Ono Establish Collaboration
with Focus on Bioactive Lipid Discovery Research
June 30, 2011 Sheila Gujrathi, M.D. Named Chief Medical Officer of Receptos
January 27, 2011 Receptos Initiates Clinical Trials for S1P1 Agonist Program, Aimed at Multiple Sclerosis
January 6, 2011 Receptos Announces License to Advance Structure-Based Drug Discovery
for High-Value G-Protein Coupled Receptor (GPCR) Targets
January 6, 2011 Receptos Announces Exclusive Collaboration with Lilly
December 2, 2010 Faheem Hasnain Named President and Chief Executive Officer of Receptos
November 23, 2009 Receptos Completes $25M Series A Financing
  • terms of use
  • privacy
  • home
  • about
  • clinical pipeline
  • research & technology
  • corporate partnering
  • contact
© 2012 Receptos, Inc. All Rights Reserved.